Held in Chicago, ACC 2025 is the premier event for exploring breakthroughs in cardiovascular research. Attendees will benefit from high-impact sessions, hands-on workshops, and networking opportunities. Our team will share key insights and discuss initiatives aimed at addressing challenges in heart health. Whether you’re looking to expand your research capabilities or collaborate on innovative treatments, we’re eager to connect with you.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
